Daniel R. Chevallard Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Daniel R. Chevallard.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Daniel R. Chevallard. Daniel R. Chevallard is CFO and COO in Viracta Therapeutics, Inc. ($SNSS) and Chief Financial Officer in Regulus Therapeutics Inc. ($RGLS).
Latest Insider Trading Transactions of Daniel R. Chevallard
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 30 2021 | SNSS | Viracta Therapeuti ... | Chevallard Daniel R. | CFO and COO | Option Exercise | A | 8.74 | 78,912 | 689,691 | 78,912 | |
| Jul 02 2019 | RGLS | Regulus Therapeuti ... | Chevallard Daniel R. | Chief Financial Off ... | Sell | S | 1.31 | 2,669 | 3,500 | 77,870 | 80.5 K to 77.9 K (-3.31 %) |
| May 16 2019 | RGLS | Regulus Therapeuti ... | Chevallard Daniel R. | Chief Financial Off ... | Option Exercise | A | 0.95 | 8,000 | 7,600 | 7,500 | |
| May 16 2019 | RGLS | Regulus Therapeuti ... | Chevallard Daniel R. | Chief Financial Off ... | Sell | S | 1.41 | 10,000 | 14,089 | 80,539 | 90.5 K to 80.5 K (-11.04 %) |
| May 16 2019 | RGLS | Regulus Therapeuti ... | Chevallard Daniel R. | Chief Financial Off ... | Grant | A | 0.00 | 55,414 | 0 | 90,539 | 35.1 K to 90.5 K (+157.76 %) |
| Apr 03 2019 | RGLS | Regulus Therapeuti ... | Chevallard Daniel R. | Chief Financial Off ... | Sell | S | 0.98 | 3,253 | 3,192 | 9,372 | 12.6 K to 9.4 K (-25.77 %) |
| Feb 06 2019 | RGLS | Regulus Therapeuti ... | Chevallard Daniel R. | Chief Financial Off ... | Option Exercise | A | 0.95 | 30,000 | 28,500 | 30,000 | |
| Feb 06 2019 | RGLS | Regulus Therapeuti ... | Chevallard Daniel R. | Chief Financial Off ... | Grant | A | 0.95 | 30,000 | 28,500 | 34,578 | 4.6 K to 34.6 K (+655.31 %) |
| Feb 06 2019 | RGLS | Regulus Therapeuti ... | Chevallard Daniel R. | Chief Financial Off ... | Option Exercise | A | 0.95 | 30,000 | 28,500 | 30,000 | |
| Feb 06 2019 | RGLS | Regulus Therapeuti ... | Chevallard Daniel R. | Chief Financial Off ... | Grant | A | 0.95 | 30,000 | 28,500 | 34,578 | 4.6 K to 34.6 K (+655.31 %) |
| May 21 2018 | RGLS | Regulus Therapeuti ... | Chevallard Daniel R. | Chief Financial Off ... | Option Exercise | A | 0.71 | 250,000 | 177,500 | 250,000 | |
| Jan 05 2018 | RGLS | Regulus Therapeuti ... | Chevallard Daniel R. | Chief Financial Off ... | Option Exercise | A | 1.24 | 350,000 | 434,000 | 350,000 | |
| Jul 25 2017 | RGLS | Regulus Therapeuti ... | Chevallard Daniel R. | Chief Financial Off ... | Buy | P | 0.91 | 54,945 | 50,000 | 59,415 | 4.5 K to 59.4 K (+1,229.19 %) |
| May 12 2017 | RGLS | Regulus Therapeuti ... | Chevallard Daniel R. | Chief Financial Off ... | Option Exercise | A | 1.65 | 100,000 | 165,000 | 100,000 |
Page: 1